Faculty
Lilian M. Abbo,
MD, MBA, FIDSA, FACHE
Associate CMO Infectious Diseases
Professor of Clinical Infectious Diseases
Jackson Health System
University of Miami Miller School of Medicine
Miami Transplant Institute
Miami, FL
Dr. Abbo is the Associate Chie fMedical Officer at Jackson Health System and a Professor of Clinical Infectious Diseases at the University of Miami Miller School of Medicine and the Miami Transplant Institute. She oversees across Jackson Health System, 7 acute care hospitals (including pediatrics and behavioral health), 2 nursing homes, 5 urgent care centers and 3 of the Miami Dade County jails.
Dr.Abbo graduated from the Universidad Central de Venezuela and completed her residency trainings at Jacobi Medical Center, NY and Mount Sinai Medical Center, Miami Beach, and a fellowship in Infectious Diseases at Jackson Memorial Hospital. She holds an Executive master’s in business administration (MBA )from the University of Miami Herbert Business School and a certification for Artificial Intelligence in Healthcare from MIT.
Dr.Abbo’s research is focused on the management of multi drug resistant infections, infection prevention, antimicrobial stewardship, treatment of complex solid organ transplant patients and AI. Dr. Abbo is the past president of Women in Academic Medicine at the University of Miami Miller School of Medicine,and a Fellow of the 25th Executive Leadership in Academic Medicine (ELAM). Dr.Abbo is also a Fellow of the Infectious Diseases Society of America (IDSA) and a Fellow of the American College of Healthcare Executives (FACHE).
Martin J. Blaser,
MD
Henry Rutgers Chair of the Human Microbiome
Professor of Medicine and Pathology & Laboratory Medicine
Robert Wood Johnson Medical School New
Brunswick, NJ
Director
Center for Advanced Biotechnology and Medicine
Rutgers University
Piscataway, NJ
Dr. Blaser holds the Henry Rutgers Chair of the Human Microbiome at Rutgers University, where he also serves as Professor of Medicine and Pathology & Laboratory Medicine, and as Director of the Center for Advanced Biotechnology and Medicine. Previously, he served as Chair of the Department of Medicine at New York University. A physician and microbiologist, Dr. Blaser has been studying the relationships we have with our persistently colonizing bacteria .His work over 40 years focused on Campylobacter species and Helicobacter pylori, which also are model systems for understanding the interactions of residentia lbacteria with their hosts. Over the last 20 years, he has also been actively studying the relationship of the human microbiome with health and important diseases including asthma, obesity, diabetes, and cancer.
Dr. Blaser has served as the advisor to many students, post-doctoral fellows, and junior faculty. He served as the founding Chair of the Presidential Advisory Council for Combating Antibiotic Resistant Bacteria (PACCARB) for two terms from 2015-2023. He holds 26 U.S.patents, has authored over 600 original articles, and he wrote Missing Microbes, a book targeted to general audiences, now translated into 20 languages.
Robert A. Bonomo, MD, FIDSA, AAP, AAM, FESCMID
Associate Chief of Staff for Academic Affairs
Director, Coordinating Center, VA Science and Health Initiative to Combat Infectious and Life-Threatening Diseases (VA SHIELD)
Clinician Scientist Investigator, Veterans Health Administration
Louis Stokes Cleveland VA Medical Center
Senior Associate Dean Director,
CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology Distinguished University Professor of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics
Case Western Reserve University School of Medicine
Cleveland, OH
Dr. Bonomo was also the Chief of the Medical Service at the Cleveland VA and Vice Chair for Veterans Affairs in the Department of Medicine at University Hospitals of Cleveland for nine years.
His research interests include the mechanistic basis of resistance to ß-lactam antibiotics and ß-lactamase inhibitors in Gram-negative and Mycobacteria, discovery of novel therapeutic agents effective agains tmultidrug-resistant (MDR) pathogens ,the molecular epidemiology of MDR Gram-negative bacteria in long term care facilities and in immunocompromised patients, infections in the elderly, and the implementation of molecular diagnostics in clinical care of elderly patients with infectious disease. He was Co-Director of the Laboratory Center of the NIH Sponsored Antibacterial Resistance Leadership Group (ARLG).
Susan L. Davis, PharmD, FIDP
Clinical Professor and Associate Dean for Pharmacy
Wayne State University
Detroit, MI
Dr .Davis is a Clinical Professor and Associate Dean for Pharmacy at Wayne State University in Detroit, MI. For 16 years she maintained a clinical appointment as an Infectious Diseases Pharmacy Specialist at Henry Ford Health System. She is a graduate of the University of Michigan, completed her residency training at Detroit Receiving Hospital, and a fellowship in Infectious Diseases Outcomes Research at Wayne State University.
Dr. Davis has published over 100 peer-reviewed manuscripts. Her awards for practice, teaching and research include the American Society of Health System Pharmacists New Preceptor of the Year, the SIDP Clinician of the Year, the Wayne State University College of Pharmacy and Health Sciences Research Excellence Award, and the WSU Board of Governors Faculty Recognition Award.
Dr. Davis is a board member of Making a Difference in Infectious Diseases, having participated in MAD-ID since 2003. She is a past president of the Society of Infectious Diseases Pharmacists and active member of many other professional and academic societies. When not in meetings she enjoys working with pharmacists, fellows, and students to enhance antimicrobial stewardship,implementpractice-basedresearch, and advance the pharmacy profession.
Elizabeth S. Dodds Ashley, PharmD, MHS, FCCP,
FIDP, BCIDP
Professor in Medicine
Division of Infectious Diseases & International Health
Operations Director
DASON Duke Center for Antimicrobial Stewardship and Infection Prevention
Durham, NC
Dr. Dodds Ashley is a Professor of Medicine and Operations Director for the Duke Antimicrobial Stewardship Outreach Network (DASON) based at Duke University. She has been an active antimicrobial stewardship pharmacist for more than 20 years. Her work and research in stewardship span a variety of patient care settings including large academic medical centers, community hospitals and long term care facilities.
She has served as a member of the Antimicrobial Resistance Working Group at the Centers for Disease Control, and an expert panel member of the Transatlantic Taskforce for Antimicrobial Resistance among other appointments. She is a current liaison member and first pharmacist on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) representing SIDP. She is actively involved in several professional societies engaged in stewardship including SHEA and SIDP for which recently served as President.
Erin R. Fox, PharmD, MHA, BCPS, FASHP
Associate Chief Pharmacy Officer, Shared Services
University of Utah Health
Salt Lake City, UT
Dr. Fox is Associate Chief Pharmacy Officer of Shared Services at University of Utah Health and is responsible for drug information and drug policy, pharmacy informatics, purchasing, billing, 340B, and antimicrobial stewardship. She also serves as Professor (adjunct) in the Department of Pharmacotherapy at the University of Utah College of Pharmacy. She and her team have provided drug shortage information for the ASHP Drug Shortage Resource Center since 2001. Erin serves as a media resource and advocate for changes to improve the ongoing drug shortage situation. She has published over 40peer-reviewed articles related to drug shortages, including the ASHP guidelines on managing drug shortages.
Dr. Fox is recognized as an expert in drug shortages and has received the ISMP Cheers Award and the ASHP Award of Excellence for efforts related to drug shortages. She served as a member of the National Academies of Sciences, Engineering, and Medicine Committee on Security of America’s Medical Product Supply Chain. Dr. Fox testified for the Senate Homeland Security and Government Affairs Committee hearing on drug shortages in March, 2023
Kevin W. Garey, PharmD, MS
Professor and Chair
University of Houston College of Pharmacy
Houston, TX
Dr.Garey is also an Adjunct Professor at the University of Texas School of Public Health and a Clinical Specialist and Researcher at Baylor St.Luke’s Medical Center, Houston, Texas. He received a Bachelor of Science in Pharmacy degree from Dalhousie University in Halifax, Nova Scotia, Canada, a Doctor of Pharmacy from SUNY Buffalo in Buffalo, NY, and a Masters of Science in Biometry from the University of Texas School of Public Health. Postdoctoral training includes a pharmacy practice residency at Bassett Healthcare, Cooperstown, NY and infectious disease specialty residency and fellowship training at the University of Illinois at Chicago, Chicago, IL.
Dr. Garey is a Fellow of the Infectious Diseases Society of American (IDSA) and a member of the IDSA-Society of Healthcare Epidemiology of America (SHEA) practice guidelines for C. difficile infection. He is an active member of the Society of Infectious Diseases Pharmacists (SIDP) and a Fellow of the American Society of Health-system Pharmacists (FASHP) and American College of Clinical Pharmacy (FCCP). He has been awarded several national awards including the ASHP Best Practice Award in Health-system Pharmacy Administration (2010), the ASHP Drug Therapy Research Award (2007), the SIDP Impact Paper in Infectious Diseases Pharmacotherapy Research Award (2007, 2012), the ACCP Russell Miller Award (2022), and the ASHP Sustained Contribution to the Literature Award (2023). Dr. Garey's research is supported by the National Institute of Health, the Centers for Disease Control and Prevention, and the biotechnology industry. He has published over 275 manuscripts centered on clinical and translational research in healthcare associated infections including healthcare-related infections,candidemia, and Clostridium difficile infection.
Timothy P. Gauthier, PharmD, BCPS, BCIDP
Antimicrobial Stewardship Clinical Program Manager
Baptist Health South Florida
Clinical Pharmacy Enterprise
Miami, FL
Dr. Gauthier completed his PharmD at Northeastern University in 2008, then did 2 years of residency at Jackson Memorial Hospital in Miami to specialize in infectious disease. He worked for Nova Southeastern University with a practice site at Jackson Memorial for 5 years, coordinated antimicrobial stewardship for the Miami Veterans Affairs Healthcare System for 5 years, and since late-2019 serves as the antimicrobial stewardship clinical program manager and PGY2 ID residency program director for Baptist Health South Florida (includes 12 hospitals and over 100 outpatient centers).
He is professionally engaged on many fronts, but is best known by the pharmacy community for his websites IDstewardship.com andLearnAntibiotics.com as well as his presence on social media @IDstewardship, where he advocates for antimicrobial stewardship and clinical pharmacy.
Jeffrey A. Goad, PharmD, MPH, APh, FAPhA, FISTM, FCPhA, FCSHP, CTH
Professor of Pharmacy Practice
Associate Dean of Academic Affairs
Chapman University School of Pharmacy
Irvine, CA
Dr.Goad is a Tenured Professor of Pharmacy Practice and Associate Dean of Academic Affairs at Chapman University School of Pharmacy.He received his Doctor of Pharmacy degree from the USC School of Pharmacy and Master of Public Health from the Keck School of Medicine at USC. He completed a residency in pediatric pharmacy practice at Children's Hospital Los Angeles and holds the Certificate of Knowledge in Travel Health from the International Society of Travel Medicine.
For over 25 years, Dr. Goad has maintained an active practice in Travel Health clinics and immunization services. He coordinates and teaches travel medicine, immunization, epidemiology, and parasitology courses. He is a national faculty and advisory board member for the American Pharmacists Association Pharmacy-Based Immunization Training Program and developer of the APhA Travel Medicine Advanced Competency Training Course. He has presented at over 300 pharmacy and medical conferences and published more than 70 articles and book chapters. Dr. Goad is President-Elect for the National Foundation for Infectious Diseases, the first pharmacist to serve in this role; past Chair and co-founder of the International Society of Travel Medicine’s Pharmacist Professional Group; past President of the California Pharmacists Association and the first pharmacist President of the California Immunization Coalition.
Infectious Diseases and Antimicrobial Stewardship Pharmacist
Stanford Health Care
Stanford,CA
Dr. Ha is manager of antimicrobial stewardship with the Stanford Antimicrobial Safety and Sustainability Program at Stanford Health Care and lecturer in infectious diseases at the Stanford University School of Medicine in Palo Alto, CA.
He also serves as PGY2 infectious diseases pharmacy residency program coordinator at Stanford Health Care. His professional and research interests include antimicrobial stewardship, infectious diseases pharmacotherapy, and public health.
David R. Ha, PharmD, BCIDP
Emily L. Heil, PharmD, MS, FIDP, BCIDP, AAHIVP
Professor
Infectious Diseases
University of Maryland School of Pharmacy
Baltimore, MD
Dr. Heil is a Professor in the Department of Practice, Sciences, and Health Outcomes Research at the University of Maryland School of Pharmacy. She serves as the Pharmacy Director of the Antimicrobial Stewardship Program and practices as an infectious disease clinical pharmacy specialist at the University of Maryland Medical Center. She completed her undergraduate and PharmD at the University of North Carolina in Chapel Hill and subsequently completed her pharmacy practice and infectious diseases pharmacy residency training at the University of North Carolina Hospitals.
She currently serves as an associate editor for Clinical Infectious Diseases and on the Infectious Diseases Society of America Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections panel. She is an active member of the Society of Infectious Diseases Pharmacists and has previously been on the board of directors.
Her research interests include antibiotic allergies, Gram-negative resistance, and domestic and international antimicrobial stewardship.
MeghanN. Jeffres, PharmD
Associate Professor
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anshutz Medical Campus
Aurora, CO
Dr. Jeffres is an Associate Professor and ID pharmacist at the University of Colorado School of Pharmacy and Hospital. She teaches infectious diseases, clinical problem solving, and conducts research about antimicrobial stewardship, antibiotic adverse reactions, allergies, and active learning.
Dr. Jeffres is a past board member of the Society of Infectious Diseases Pharmacists, current member of the MAD-ID Board, co-founder of the Infectious Diseases Educator Network, and creator of Medical Rewrites Podcast.
Melissa D. Johnson, PharmD, MHS, AAHIVP
Professor of Medicine
Division of Infectious Diseases & International Health
Duke University Medical Center
Liaison Clinical Pharmacist
Duke Antimicrobial Stewardship Outreach Network (DASON)
Durham, NC
Dr. Johnson is a Professor of Medicine in the Division of Infectious Diseases & International Health at Duke University Medical Center in Durham, North Carolina. Dr. Johnson has served as an investigator for numerous clinical trials with antifungal, antiretroviral, and antibacterial agents.
She also serves as a Liaison Clinical Pharmacist for Duke Antimicrobial Stewardship Outreach Network (DASON), which performs consulting services for more than 35 hospitals in 5 states. She is also the Immediate Past President of the Society of Infectious Diseases Pharmacists.
Sarah Kabbani,
MD, MSc
Deputy Director,
Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Atlanta, GA
Dr. Kabbani is an adult infectious disease physician and the deputy director of the Office of Antibiotic Stewardship, Division of Health care Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention.
Dr. Kabbani attended the American University of Beirut School of Medicine in Lebanon, and completed her internal medicine residency at Wayne State University in Michigan. After working as an academic hospitalist for two years at the Beaumont Health System, she joined Emory University in 2011 for her post-doctoral infectious disease fellowship. During her fellowship she completed a Master of Science in Clinical Research and was awarded an NIH T32 training grant in vaccinology. In 2016, she joined the Office of Antibiotic Stewardship, where her areas of concentration include older adults and long-term care antibiotic stewardship.
Ashlan J. Kunz Coyne, BS, PharmD, MPH
Assistant Professor
Clinical and Translational Science
Department of Pharmacy Practice & Science
University of Kentucky College of Pharmacy
Lexington, KY
Dr. Kunz Coyne is an Assistant Professor of Clinical and Translational Science in the Department of Pharmacy Practice & Science at the University of Kentucky College of Pharmacy. Her research focuses on the identification and treatment of multidrug-resistant (MDR) bacterial infections with specific evaluations of (1) antimicrobial resistant (AMR) mechanisms and their impact on antimicrobial effectiveness, (2) antimicrobial pharmacokinetic/pharmacodynamic (PK/PD) optimization and the (3) use of novel antimicrobials for refractory AMR infections.
Dr.Kunz Coyne received her Doctor of Pharmacy degree from the University of Florida. She then pursued post-graduate training at UF Health Jacksonville in Jacksonville, Florida, by completing an acute care PGY1 residency followed a PGY2 in infectious diseases. Upon completion of her residency, she maintained her interest in infectious diseases and pursued a PK/PD and health outcomes postdoctoral research fellowship at Wayne State University under the mentorship of Dr.Michael J. Rybak, while concurrently completing her Masters in Public Health.
Joseph L. Kuti, PharmD, FIDP, FCCP
Director
Center for Anti-Infective Research and Development
Hartford Hospital
Hartford, CT
Dr. Kuti is Director of the Center for Anti-Infective Research and Development at Hartford Hospital in Hartford, Connecticut. He received his Bachelor of Science and Doctor of Pharmacy degrees from Rutgers University, College of Pharmacy in Piscataway, New Jersey. He then completed a post-doctorate fellowship in Antibiotic Management and Pharmacoeconomics at Hartford Hospital.
Dr. Kuti is a member of the American Society for Health-System Pharmacist, American Society for Microbiology, Infectious Disease Society of America, past-President, member, and honorary Fellow of the Society of Infectious Diseases Pharmacists, and member/honorary Fellow of the American College of Clinical Pharmacy. He is also an advisor to the CLSI Antibiotic Susceptibility Testing Subcommittee.
Dr. Kuti’s primary area of research includes the pharmacokinetics, pharmacodynamics, and outcomes of antimicrobial management of severe infections. His research has been published in over 200 peer-reviewed papers.
Kerry L. LaPlante, PharmD, FCCP, FIDSA, FID
Dean College of Pharmacy
University of Rhode Island
Kingston, RI
Adjunct Professor of Medicine
Brown University
Director, Rhode Island Infectious Diseases Research Program (RIID)
Providence Veterans Medical Center
Providence, RI
Dr .LaPlante serves as dean professor at the University of Rhode Island College of Pharmacy.Sheis an internationally recognized pharmaco-therapy specialist in antibiotic therapy and a pharmacist-scientist who serves as a global advisor for industry-based research and development programs and contributes to international initiatives. She is the author of the leading textbook Antimicrobial Stewardship Principles and Practices and has presented more than 100 invited lectures worldwide and authored over 140 peer-reviewed articles featured in prestigious journals.
Dr. LaPlante has extensively researched biofilms and championed optimal antimicrobial use to prevent resistance and enhance patient outcomes. She played a pivotal role in establishing the Rhode Island Department of Health’s Antimicrobial Stewardship and Environmental Task Force. She was appointed by the governor of RI to the COVID-19 vaccine subcommittee. She advises organizations like the Centers for Disease Control and Prevention, PEW Research Center, and The Joint Commission.
Dr. LaPlante is an elected fellow of the Infectious Diseases Society of America, the American College of Clinical Pharmacy, anda past president of the Society of Infectious Diseases Pharmacists.
Conan MacDougall, PharmD, MAS, BCPS, BCIDP
Co-Vice Dean for PharmD Education, Professor of Clinical Pharmacy
Department of Clinical Pharmacy
University of California San Francisco School of Pharmacy
San Francisco, CA
Dr. MacDougall teaches pharmacy, medical, and nursing trainees at UCSF, for which he has twice received the Academic Senate Campus Award for Distinction in Teaching. A member of the School of Medicine’s Academy of Medical Educators, he has been recognized as an Emerging Teaching Scholar by the American Academy of Colleges of Pharmacy and received the Albert B. Prescott Pharmacy Leadership Award from the Pharmacy Leadership & Education Institute.
Dr. MacDougall provides clinical service to the Infectious Diseases Consult Service and Antimicrobial Stewardship Program at UCSF Medical Center. His research interests include new approaches for interactive learning around appropriate antimicrobial use and the pharmacoepidemiology of antimicrobial use in hospitals. He is co-author of Antibiotics Simplified, Antimicrobial Section Editor for Goodman & Gilman’s The Pharmacological Basis of Therapeutics, and a chapter author in Principles and Practice of Infectious Diseases, Poisoning and Drug Overdose, and Emergency Management of Infectious Diseases.
Dr. MacDougall's original research and reviews have been published in Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Clinical Microbiology Reviews, Emerging Infectious Diseases, Archives of Internal Medicine, American Journal of Pharmaceutical Education, and Pharmacotherapy. He currently serves as Chair of the Specialty Council on Infectious Diseases for the Board of Pharmaceutical Specialties and is an active member of the Medical Education Community of Practice of the Infectious Diseases Society of America.
Taylor Morrisette, PharmD, MPH
Assistant Professor
Clinical Pharmacy and Outcomes Sciences
Medical University of South Carolina (MUSC) College of Pharmacy
Clinical Pharmacy Specialist
Infectious Diseases and Antimicrobial Stewardship
MUSC Health
Charleston, SC
Dr. Morrisette is an Assistant Professor at the Medical University of South Carolina College of Pharmacy within the Department of Clinical Pharmacy and Outcomes Sciences and a Clinical Pharmacy Specialist in Infectious Diseases/Antimicrobial Stewardship at MUSC Health. He completed his PharmD at Wingate University School of Pharmacy in Hendersonville, North Carolina, Master of Public Health at Wayne State University in Detroit, Michigan, and PGY-1 residency at Methodist University Hospital in Memphis, Tennessee. Dr. Morrisette has also completed a PGY-2 infectious diseases residency at the University of Colorado in Aurora, Colorado, and a postdoctoral research fellowship in antimicrobial pharmacokinetics/pharmacodynamics and infectious diseases health outcomes at the Anti-Infective Research Laboratory at Wayne State University in Detroit, Michigan.
Dr. Morrisette has contributed to over 50 peer-reviewed manuscripts and book chapters and over 90 abstracts within the area of infectious diseases therapeutics and antimicrobial stewardship.
Ryan P. Mynatt, PharmD, BCPS
Clinical Pharmacist
Infectious Diseases & Outpatient Parenteral Antimicrobial Therapy (OPAT)
University of Kentucky Health Care
Lexington, KY
Dr. Mynatt received his Bachelors of Science Degree in Chemistry from Morehead State University, in Morehead, Kentucky. He later received his Doctor of Pharmacy from the University of Kentucky College of Pharmacy. He subsequently completed both his Post-Graduate Year 1 Pharmacy Practice Residency and Post-Graduate Year 2 Infectious Diseases Residency at the University of Kentucky HealthCare, Chandler Medical Center, in Lexington, Kentucky. Upon graduation he served a sa Clinical Pharmacist in Infectious Diseases & Antimicrobial Stewardship at the Detroit Receiving Hospital, part of the Detroit Medical Center for nine years. During this time, he served as the residency program director for their PGY-2 Infectious Diseases Pharmacy Residency program. He returned to the University of Kentucky in 2019 and has been championing the creation of the adult, outpatient parenteral antimicrobial therapy program for the Enterprise, and currently serves as a clinical pharmacist in infectious diseases and outpatient parenteral antimicrobial therapy at the University of Kentucky. He is a current member of ASHP and is board certified in pharmacotherapy.
Dr. Mynatt’s current research interests include the pharmacokinetic and pharmacodynamics evaluation of antimicrobial therapies prescribed in OPAT, risk factors for treatment success or failure in patients receiving OPAT, as well as antimicrobial stewardship related initiatives both within his health system and surrounding region.
Priya Nori, MD, FSHEA, FIDSA
Antimicrobial Stewardship & OPAT
Associate Professor of Medicine (ID) & Orthopedics
Montefiore Health System
Albert Einstein College of Medicine
Bronx, NY
Dr. Nori is the Medical Director of Antimicrobial Stewardship and OPAT at the Montefiore Health System in the Bronx, NY, the chair of the SHEA stewardship committee, chair of the IDSA stewardship curriculum subcommittee, and Deputy Editor of the SHEA journal Antimicrobial Stewardship & Healthcare Epidemiology. She is an Associate Professor of Medicine (ID) and Orthopedics at the Albert Einstein College of Medicine in the Bronx, NY.
She is widely published in stewardship decision support tools, medical education, orthopedic infections, and pandemic stewardship. She was the recipient of the 2023 SHEA antimicrobial stewardship scholar award presented to her at IDWeek2023.
Mandee M. Noval, PharmD, BCIDP
Assistant Professor
Department of Practice Science and Health Outcomes Research
University of Maryland School of Pharmacy
Baltimore, MD
Dr. Noval is an Assistant Professor at the University of Maryland School of Pharmacy and an infectious diseases clinical pharmacist at the University of Maryland Medical Center. She also serves as the PGY2 infectious diseases pharmacy residency program coordinator at the University of Maryland School of Pharmacy.
Her clinical practice and research interests include clinical outcomes in outpatient parenteral antimicrobial therapy (OPAT), antimicrobial stewardship, infections in vulnerable populations, and antibiotic allergies.
Ravi Patel,PharmD, MBA, MS
Lead Innovation Advisor
University of Pittsburgh School of Pharmacy
Pittsburgh, PA
Dr. Patel is the Lead Innovation Advisor at the University of Pittsburgh School of Pharmacy where he leads the Pharmacy Innovation Lab. Dr.Patel’s efforts focus on the intersection of health, technology, data, and design. This work includes the research and teaching in user-centered design of health technology, evaluation of consumer technology, and application of creativity and innovation in pharmacy education and practice.
Dr. Patel serves on the Clinician Advisory Group of the Digital Therapeutic Alliance, works with the team at Blueberry Pharmacy, an independent cost-plus pharmacy in Pittsburgh, and serves as advisor to organizations and start-ups that leverage technology in healthcare.
Kelly R. Reveles, PharmD, PhD, BCPS, BCIDP
Associate Professor
College of Pharmacy The University of Texas at Austin
Austin, TX
Adjoint Associate Professor
Dr. Reveles is an Associate Professor at The University of Texas at Austin College of Pharmacy and an Adjoint Associate Professor at The University of Texas Health Science Center at San Antonio School of Medicine. She received her Doctor of Pharmacy degree from UT Austin in 2010. She also completed a multi-disciplinary, multi-institutional Translational Science PhD degree from UT Austin, UT Health Science Center San Antonio, and UT San Antonio in 2014.
Dr. Reveles’ long-term research goal is to reduce the incidence and improve the outcomes of healthcare-associated infections by designing, testing, and implementing effective clinical strategies.Her current research focus is the prevention and treatment of Clostridioides difficile infections and innovative methods to improve the translation of clinical research findings into practice. Her research approach emphasizes multidisciplinary, collaborative research across the translational spectrum, including basic science, preclinical animal studies, human clinical studies, and pharmacoepidemiology studies. She is specifically interested in identifying and implementing clinical strategies for the prevention and treatment of C. difficile infections using national data, the impact of drugs and diseases on the gut microbiome, and the development of microbiome-targeted therapies to mitigate these effects. She has published over 90 peer-reviewed papers and has been awarded over $5 million in federal grants to support her research.
Warren Rose, PharmD, MPH
Associate Professor of Pharmacy & Medicine
School of Pharmacy University of Wisconsin-Madison
Madison, WI
Dr. Rose is a tenured Associate Professor of Pharmacy and Medicine at the University of Wisconsin-Madison. His translational research employs three distinct themes of pharmacology with multiple layers of projects to study multi-drug resistant pathogens. These research areas surround understanding the translational effects of antimicrobials including i) antibiotic efficacy such as combination therapy and resistance suppression, ii) impacts on bacterial pathogenicity (toxins and virulence factors, and iii) antibiotic effects on host-pathogen interactions including innate immune responses and pathogen immune evasion/dysregulation. His research has been continuously funded by diverse sources including NIH (NIAIDR01/R21), professional societies/organizations, and the pharmaceutical industry.
Dr. Rose has received awards from pharmacy and infectious diseases societies spanning Young Investigator of the Year to Distinguished Investigator Award in his career. He has been an appointed member to the Editorial Board of Antimicrobial Agents and Chemotherapy since 2016. He is an Honorary Fellow of both the Infectious Diseases Society of America and the American College of Clinical Pharmacy. Dr. Rose holds clinical appointments within the Department of Pharmacy at UW Health where he works with the Antimicrobial Stewardship Team.
Michael J. Rybak, PharmD, MPH, PhD
Professor of Pharmacy, Department of Pharmacy Practice
Director, Anti-Infective Research Laboratory
Eugene Applebaum College of Pharmacy & Health Sciences
Wayne State University
Detroit, MI
Dr. Rybakis also Adjunct Professor of Medicine, Division of Infectious Diseases, Emerging Center for Infectious Diseases, School of Medicine at Wayne State University, and Adjunct Clinical Professor at the University of Michigan College of Pharmacy. He is affiliated with the Detroit Medical Center and is a member of their antimicrobial stewardship committee. His research focus is antimicrobial pharmacokinetics and pharmacodynamics (PK/PD) and the assessment of infectious diseases health outcomes including their relationship to bacterial resistance.
Dr. Rybak is funded by the National Institute for Allergy and Infectious Diseases (NIAID) and via several investigator-initiated grants from the pharmaceutical Industry. He has published more than 450 manuscripts and authored more than 20 book chapters on antimicrobial PK/PD resistance, and antimicrobial stewardship. He is the editor-in-chief of the journal Infectious Diseases and Therapy, Associate Editor, Clinical Infectious Diseases and Scientific editor for Infectious Diseases for the journal Pharmacotherapy, and editorial board member for the journal Antibiotics and for Contagion.
Dr. Rybak is the recipient of a number of scholarship awards including the ACCP and ASHP awards for sustained contributions to the literature, the ACCP Therapeutics Frontiers Lecture award, and the ACCP Infectious Diseases Practice Network Distinguished Investigator award and was recently inducted into the Academy of Scholars at Wayne State University.
Katie J. Suda, PharmD, MS, FCCP
Professor (with tenure) of Medicine
Associate Director, Center for Pharmaceutical Policy and Prescribing
Director, Transition to Independence Program
University of Pittsburgh
Research Health Scientist and Associate Director
Center for Health Equity Research and Promotion
Pittsburgh, PA
Dr. Suda received her PharmD from Drake University and a Master’s in epidemiology at the University of Tennessee. Dr. Suda’s post-doctoral training includes a residency at Baptist Memorial Health Care, a pharmacokinetics fellowship at the Clinical Pharmacokinetics Laboratory and an infectious diseases and outcomes research fellowship at the University of Illinois at Chicago.
Dr. Suda is a national expert in pharmacoepidemiology and pharmaceutical policy. As a clinical pharmacist with additional training in health outcomes and epidemiology, Dr. Suda’s research interests include antimicrobial and opioid pharmacoepidemiology, drug shortages, and effectiveness of implementation strategies to improve prescribing. Dr. Suda has received funding from federal and non-federal sources and currently manages a research portfolio of over $15million with R01, U-level and VA Merit awards as PI and Co-I from AHRQ, CDC, FDA, NIH, and the VA. Dr. Suda’s research has informed national policy on drug shortages, outpatient antibiotic stewardship, provision of VA data to state prescription drug monitoring programs, and the importance of dental prescribing in identifying solutions to the opioid epidemic and mounting bacterial resistance. Dr. Suda has served on committees and expert panels focused on evidence-based prescribing and health policy for multiple federal agencies and professional organizations. Dr. Suda has written more than 240 peer reviewed research articles in the professional literature and 16 book chapters. Dr. Suda has received awards for teaching and research, including the CDC Shepard Science Award and the SIDP Infectious Diseases Pharmacotherapy Paper Award.